KRM Ayurveda, a company in the Pharmaceuticals industry, reported revenue of ₹35 crore and net profit of ₹8.23 crore for the September 2026 quarter.
KRM Ayurveda (NSE: KRMAYURVED-SM) closed at ₹220.35 on 20 Nov 2026. Its market capitalisation is ₹468 crore and it trades at 16.0 times earnings.
Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.